Compare
PAVmed Inc. vs SANUWAVE Health, Inc. vs Lucid Diagnostics Inc. vs Beyond Air, Inc.
| Latest fiscal year | PAVmed Inc. PAVMRevenue covers only part of its income (partial revenue) | SANUWAVE Health, Inc. SNWV | Lucid Diagnostics Inc. LUCD | Beyond Air, Inc. XAIR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-31 |
| Revenue | n/a | $44.05M | $4.71M | $7.68M |
| Revenue growth (YoY) | n/a | +35.0% | +8.3% | +107.3% |
| Gross margin | n/a | 77.1% (computed) | -41.7% (computed) | 3.3% |
| Operating margin | n/a | 11.2% | n/m | -378.2% |
| Net margin | n/a | 26.8% | n/m | -433.0% |
| Net income | $401.0K | $11.81M | -$58.01M | -$33.25M |
| EPS (Diluted) | -$5.63 | $0.41 | n/a | -$4.01 |
| Operating cash flow | -$5.21M | $3.88M | -$46.48M | -$18.14M |
| Free cash flow | -$5.24M | $1.93M | -$46.68M | -$19.17M |
| Cash & equivalents | $1.54M | $11.96M | n/a | $6.74M |
| Total assets | $38.81M | $37.34M | $40.45M | $35.38M |
| Total liabilities | $16.51M | $35.72M | $29.51M | $29.18M |
| Shareholders' equity | $33.97M | $1.62M | $10.94M | $6.13M |
| Return on year-end equity | 1.2% | 729.6% | -530.4% | -542.8% |
| Shares outstanding | 927.9K | 8.59M | 131.10M | 11.79M |
Revenue, most recent five fiscal years
| Fiscal year | PAVmed Inc. | SANUWAVE Health, Inc. | Lucid Diagnostics Inc. | Beyond Air, Inc. |
|---|---|---|---|---|
| Latest | n/a | $44.05M Ended 2025-12-31 | $4.71M Ended 2025-12-31 | $7.68M Ended 2026-03-31 |
| 1 year earlier | n/a | $32.63M Ended 2024-12-31 | $4.35M Ended 2024-12-31 | $3.71M Ended 2025-03-31 |
| 2 years earlier | n/a | $20.40M Ended 2023-12-31 | $2.43M Ended 2023-12-31 | $1.16M Ended 2024-03-31 |
| 3 years earlier | n/a | $16.74M Ended 2022-12-31 | $377.0K Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | $13.01M Ended 2021-12-31 | $500.0K Ended 2021-12-31 | n/a |